Field Trip Health & Wellness to Participate in Upcoming November Conferences
TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) — Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), the global leader…
TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), the global leader in the development and delivery of psychedelic therapies, will participate in the following industry and investor conferences in November.
- Wonderland Microdose
Format: Panel Presentation with Mujeeb Jafferi, President, Field Trip Health & Wellness, “Are Apps the Future of Psychedelic Therapy?”
Date/Time: Friday, November 4, at 1:20 p.m. ET
Location: Second Stage, Mana Wynwood Convention Center, Miami
Registration Link: https://microdose.buzz/wonderland/
- HTLH 2022
Format: Company Presentation with Ronan Levy, Chairman & CEO, Field Trip Health & Wellness
Date/Time: Tuesday, November 15, 2022, 11:50 a.m. PT
Location: The Newsroom Stage, Venetian Expo, Las Vegas
Registration Link: https://www.hlth.com/2022event/register
- ReMind Psychedelics Business Forum
Format: Panel Presentation with Ronan Levy, Chairman & CEO, Field Trip Health & Wellness, “The Future of Psychedelics: Entrepreneurial Perspectives”
Date/Time: Tuesday, November 15, 2022, at 3:45 p.m. PT
Location: Las Vegas Convention Center, Las Vegas
Registration Link: https://registration.experientevent.com/showmjc221/
Field Trip’s management team will also hold one-on-one investor meetings throughout the duration of the conferences. Institutional investors interested in scheduling a meeting, please contact KCSA Strategic Communications at FieldTripIR@kcsa.com.
About Field Trip Health & Wellness Ltd.
With a large global community of psychedelic-interested people, proprietary psychedelic therapies generating transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.
Learn more at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram: @fieldtriphealth.
To receive company updates about Field Trip and to be added to the email distribution list please sign up here.
Download Field Trip’s app here.
Cautionary Note Regarding Forward-Looking Information
This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to the Company, can be located on the SEDAR website at www.sedar.com.
Neither TSX Venture Exchange, or its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.
Field Trip Health & Wellness:
Chairman & CEO
Phil Carlson / Sophia Bashford
KCSA Strategic Communications
(646) 573-0776 / (929) 246-7307
SOURCE Field Trip Health & Wellness Ltd.
psychedelics psychedelic field trip health field trip
Compass Pathways Gets Good News On Psilocybin Patent Journey
Rastafari and Psychedelic Medicines
Compass Pathways’ Stock Soars as COMP360 Receives Patent Victory
Candyflipping: New MindMed-Owned Study Looks at Combining MDMA and LSD
Nirvana Moves Forward With MedSmart Acquisition
LSD17 hours ago
Cannabis Coalition Forms To Push Biden On Federal Reform: Will It Work This Time?
LSD16 hours ago
Study Shows New Mechanism For How Psychedelics Promote Plasticity
Public Companies16 hours ago
Nirvana Moves Forward With MedSmart Acquisition
Psilocybin14 hours ago
Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
Markets & Investing14 hours ago
Psychedelics in Dubai: Therapeutic Role of Psychedelics Explored at Conference in the Arab Region
Psilocybin7 hours ago
Oregon Pioneers New Psilocybin Business Models
Markets & Investing5 hours ago
The 7 Most Promising Penny Stocks to Buy in June